Associate Professor, Medicine, University of Washington School of Medicine
Oncology
Dr. Sunil R. Hingorani, MD
|
|
Give Review
Sunil Hingorani is an expert in the field of Oncology. He went to medical school at Yale University School of Medicine. Yale University School of Medicine is a one of the best medicals schools. Yale University School of Medicine is ranked 7/57 in Research/PrimaryCare. Dr. Sunil R. Hingorani is a published doctor and has 34 publications published. The lastest was: 'T Cells Engineered against a Native Antigen Can Surmount Immunologic and Physical Barriers to Treat Pancreatic Ductal Adenocarcinoma.'
Publications
- T Cells Engineered against a Native Antigen Can Surmount Immunologic and Physical Barriers to Treat Pancreatic Ductal Adenocarcinoma.
- Intercepting Cancer Communiques: Exosomes as Heralds of Malignancy.
- Prognostic factors of survival in a randomized phase III trial (MPACT) of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone in patients with metastatic p...
- Cross-Species Antibody Microarray Interrogation Identifies a 3-Protein Panel of Plasma Biomarkers for Early Diagnosis of Pancreas Cancer.
- Spatiotemporal Proteomic Analyses during Pancreas Cancer Progression Identifies Serine/Threonine Stress Kinase 4 (STK4) as a Novel Candidate Biomarker for Early Stage ...
- Molecular pathways: myeloid complicity in cancer.
- Cellular and molecular conspirators in pancreas cancer.
- Response to chauhan et Al.: interstitial pressure and vascular collapse in pancreas cancer-fluids and solids, measurement and meaning.
- Stromal re-engineering to treat pancreas cancer.
- Targeted depletion of an MDSC subset unmasks pancreatic ductal adenocarcinoma to adaptive immunity.
- Re-adapting T cells for cancer therapy: from mouse models to clinical trials.
- Hypoxia Triggers Hedgehog-Mediated Tumor-Stromal Interactions in Pancreatic Cancer.
- Hyaluronan, fluid pressure, and stromal resistance in pancreas cancer.
- Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma.
- Isoform-specific upregulation of palladin in human and murine pancreas tumors.
- Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer.
- A phase I trial of the oral, multikinase inhibitor sorafenib in combination with carboplatin and paclitaxel.
- EGCG inhibits growth, invasion, angiogenesis and metastasis of pancreatic cancer.
- Targets, trials, and travails in pancreas cancer.
- Dynamics of the immune reaction to pancreatic cancer from inception to invasion.
- The RON receptor tyrosine kinase mediates oncogenic phenotypes in pancreatic cancer cells and is increasingly expressed during pancreatic cancer progression.
- Location, location, location: precursors and prognoses for pancreatic cancer.
- Kras(G12D) and Smad4/Dpc4 haploinsufficiency cooperate to induce mucinous cystic neoplasms and invasive adenocarcinoma of the pancreas.
- N-cadherin and keratinocyte growth factor receptor mediate the functional interplay between Ki-RASG12V and p53V143A in promoting pancreatic cell migration, invasion, a...
- ATP citrate lyase inhibition can suppress tumor cell growth.
- Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice.
- Detecting and diagnosing ampullary neoplasms.
- Endogenous oncogenic K-ras(G12D) stimulates proliferation and widespread neoplastic and developmental defects.
- New pathways to pancreatic cancer.
- Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse.
- Suppression of BRAF(V599E) in human melanoma abrogates transformation.
- Targeting oncogene dependence and resistance.
- In search of an early warning system for pancreatic cancer.
Schools
Yale University
Brigham and Women39s Hospital
Conditions Treated
- Acute Leukemia
- Anemia
- Deep Vein Thrombosis (DVT)
- Myelodysplastic Syndromes
- View All
Doctors Specialties
- Hematology
- Oncology
Accepted Insurances
- Blue Cross Blue Shield
- Great West Healthcare-Cigna PPO
- Commercial Insurance Company
- Group Health Cooperative
- Medicaid
- Medicare MCR
- Molina
- Providence Health Plans
- United Healthcare
Education
-
Brigham and Women's Hospital -
Yale University School of Medicine
Helpful Reviews
Similar Doctors
|
|
Dr. David White, MD |
|
|
Dr. Mary L. Disis, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Craig R. Nichols, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Christine C. Kaiser, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. William H. Schubach, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Carl A. Blau, MD |
|
|
Dr. George E. Georges, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Brent L. Wood, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Brian G. Till, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Eric Y. Chen, MD |
|
|
Dr. Jeffrey Chou, MD |
|
|
Dr. Romeo A. De Claro, MD |
|
|
Dr. Maika Onishi, MD |
|
|
Dr. Derek L. Stirewalt, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Michael W. Schmitt, MD |
|
|
Cameron J. Turtle, MB BS |